Thierry M. Jahan, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Thierry M. Jahan, MD

Clinical Professor, Department of Medicine, UCSF
Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology, UCSF

Phone: (415) 885-3882 (appts)
Box 1705, UCSF
San Francisco, CA 94143-1705

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Education

Columbia University, New York, NY, B.A., 1983, Psychology
George Washington University School of Medicine, Washington, DC, M.D., 1987, Medicine


Professional Experience

  • 1987-1990
    Resident, Department of Medicine Cedars-Sinai Medical Center/UCLA, Los Angeles CA
  • 1990-1991
    Kennamer/General Internal Medicine Fellow, Division of General Internal Medicine, Department of Medicine Cedars-Sinai Medical Center/UCLA, Los Angeles CA
  • 1991-1994
    Clinical Fellow, Division of Hematology/Oncology, Department of Medicine University of California San Francisco CA
  • 1994-2004
    Assistant Clinical Professor of Medicine, Division of Hematology/Oncology, University of California San Francisco
  • 2006-2012
    Associate Clinical Professor of Medicine, and Director, Clinical Services, Division of Hematology/Oncology UCSF Helen Diller Family Comprehensive Cancer Center, Mount Zion campus Department of Medicine University of California, San Francisco
  • 2012-present
    Clinical Professor of Medicine, and Director, Clinical Services, Division of Hematology/Oncology UCSF Helen Diller Family Comprehensive Cancer Center, Mount Zion campus Department of Medicine University of California, San Francisco

Honors & Awards

  • 1996
    Outstanding Teacher Award, UCSF/Mt. Zion Medical Center
  • 2006
    1st Annual Friend of the Palliative Care Service Award.

Selected Publications

  1. Intraoperative Radiotherapy in the Management of Locally Recurrent Extremity Soft Tissue Sarcoma. Sarcoma. 2015; 2015:913565.
    View on PubMed
  2. Non-small cell lung cancer, version 6.2015. J Natl Compr Canc Netw. 2015 May; 13(5):515-24.
    View on PubMed
  3. Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw. 2014 Dec; 12(12):1738-61.
    View on PubMed
  4. A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non-Small-Cell Lung Cancer. J Thorac Oncol. 2014 Oct; 9(10):1532-9.
    View on PubMed
  5. Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma. Clin Cancer Res. 2014 Dec 1; 20(23):5927-36.
    View on PubMed
  6. Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer. Clin Lung Cancer. 2014 Nov; 15(6):426-32.
    View on PubMed
  7. Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity. Am J Clin Oncol. 2014 Aug; 37(4):350-5.
    View on PubMed
  8. The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer. Int J Clin Oncol. 2015 Feb; 20(1):59-69.
    View on PubMed
  9. Aggressive and minimally invasive surgery for pulmonary metastasis of sarcoma. J Thorac Cardiovasc Surg. 2014 Apr; 147(4):1193-200; discussion 1200-1.
    View on PubMed
  10. A novel use of foley catheters to prevent injury to the pelvic viscera during stereotactic radiosurgery for undifferentiated pleomorphic sarcoma of the sacrum. Perm J. 2014; 18(3):e146-9.
    View on PubMed
  11. VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer. J Thorac Dis. 2013 Oct; 5(5):578-84.
    View on PubMed
  12. Desmoplastic fibroma of the spine causing severe mediastinal compression and brachial plexus encasement: report of 2 cases. J Neurosurg Spine. 2013 Oct; 19(4):515-20.
    View on PubMed
  13. Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw. 2013 Jun 1; 11(6):645-53; quiz 653.
    View on PubMed
  14. Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2013 May 1; 11(5):562-76.
    View on PubMed
  15. Small cell lung cancer. J Natl Compr Canc Netw. 2013 Jan 1; 11(1):78-98.
    View on PubMed
  16. Non-small cell lung cancer. J Natl Compr Canc Netw. 2012 Oct 1; 10(10):1236-71.
    View on PubMed
  17. Determination of cutpoints for low and high number of symptoms in patients with advanced cancer. J Palliat Med. 2012 Sep; 15(9):1027-36.
    View on PubMed
  18. A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer. Lung Cancer. 2012 Oct; 78(1):57-62.
    View on PubMed
  19. One size does not fit all lung cancer patients. J Thorac Oncol. 2012 May; 7(5):945.
    View on PubMed
  20. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol. 2012 May 1; 30(13):1447-55.
    View on PubMed

Go to UCSF Profiles, powered by CTSI